HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Abstract
Mice immunized with heat-inactivated, whole yeast-form cells (Y cells) of Candida albicans developed intense, specific humoral and cell-mediated immune responses. However, they were modestly protected against a lethal challenge by the fungus, and their sera did not confer passive protection upon nonimmunized animals. Surprisingly, this immune serum conferred an elevated degree of passive protection to normal and SCID mice when preadsorbed on whole C. albicans cells. After adsorption, no antibodies specific to mannoprotein (MP)-rich extracts or secretions were detected by indirect enzyme-linked immunosorbent assay and no serum reaction with the fungal cell surface was seen in immunofluorescence assays. However, this serum had totally preserved the level of other antibodies, in particular those reacting with beta-1,3 and beta-1,6 glucan (GG). The hypothesis that anti-GG antibodies contributed to the passive protection was suggested by the following circumstantial evidence: (i) mice immunized with C. albicans cells treated with dithiothreitol and protease (YDP cells), which exposed GG on their surfaces and generated anti-GG but not anti-MP antibodies, were substantially protected against a lethal fungus challenge; (ii) the sera, and their immunoglobulin fractions, of mice immunized with YDP cells transferred protection to nonimmune animals; and (iii) this passive protection was substantially abolished by preadsorption on GG but not on intact cells. Overall, our findings demonstrate that some anti-Candida antibodies can block the protective potential of immune serum, a potential to which anti-GG antibodies appear to contribute. Our observations may also help explain why subjects with elevated anti-Candida antibody titers, inclusive of anti-MP and anti-GG antibodies, remain nonetheless susceptible to invasive candidiasis.
AuthorsCarla Bromuro, Antonella Torosantucci, Paola Chiani, Stefania Conti, Luciano Polonelli, Antonio Cassone
JournalInfection and immunity (Infect Immun) Vol. 70 Issue 10 Pg. 5462-70 (Oct 2002) ISSN: 0019-9567 [Print] United States
PMID12228271 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Blocking
  • Antibodies, Fungal
  • Antigens, Fungal
  • Fungal Vaccines
  • Glucans
  • Membrane Glycoproteins
  • mannoproteins
Topics
  • Animals
  • Antibodies, Blocking (blood)
  • Antibodies, Fungal (blood)
  • Antigens, Fungal
  • Candida albicans (immunology, pathogenicity)
  • Candidiasis (immunology, prevention & control)
  • Disease Models, Animal
  • Female
  • Fungal Vaccines (pharmacology)
  • Glucans (immunology)
  • Humans
  • Immunization, Passive
  • Membrane Glycoproteins (immunology)
  • Mice
  • Mice, SCID

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: